Epilepsy in Cambodia-Treatment Aspects and Policy Implications: A Population-Based Representative Survey

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Bhalla, Devender ^a,b,d   Chea, Kimly ^c   Hun, Chamroeun ^c,d,e   Chan, Vichea ^d,e   Huc, Pierre ^a   Chan, Samleng ^c,d,e   Sebbag, Robert ^f   Gérard, Daniel ^f   Dumas, Michel ^a   Oum, Sophal ^c   Druet Cabanac, Michel ^a,b   Preux, Pierre Marie ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF HEALTH SCIENCES   (Cambodia)

^d Cambodian Society of Neurology   (Cambodia)

^e Calmette Hospital   (Cambodia)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; VALPROIC ACID;

ACCIDENT; ADOLESCENT; ADULT; ARTICLE; ATTENTION; BURN; CAMBODIA; CASE MANAGEMENT; CEREBROVASCULAR ACCIDENT; CHILD; CONFUSION; DIARRHEA; DRUG COST; DRUG FEVER; DRUG SAFETY; DYSKINESIA; DYSURIA; EPILEPSY; FALLING; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEALTH CARE MANPOWER; HEALTH CARE POLICY; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MICTURITION DISORDER; MORTALITY; NAUSEA; NEAR DROWNING; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRODUCTIVITY; PROGNOSIS; PSYCHOMOTOR RETARDATION; REMISSION; SCHOOL CHILD; SELF REPORT; SIDE EFFECT; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT; UNSTEADY GAIT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CAMBODIA; CHILD; COMMUNITY HEALTH CENTERS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HOUSE CALLS; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT SATISFACTION; PROGNOSIS; QUESTIONNAIRES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883493660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074817     Document Type: Article

References (47)

1. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
2. Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, et al. (2007) Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 6: 533-543.
3. Mbuba CK, Ngugi AK, Newton CR, Carter JA, (2008) The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 49: 1491-1503.
4. Lu B, Elliott JO, (2012) Beyond seizures and medications: normal activity limitations, social support, and mental health in epilepsy. Epilepsia 53: e25-28.
5. Preux PM, Chea K, Chamroeun H, Bhalla D, Vannareth M, et al. (2011) First-ever, door-to-door cross-sectional representative study in Prey Veng province (Cambodia). Epilepsia 52: 1382-1387.
6. Tran DS, Zen J, Strobel M, Odermatt P, Preux PM, et al. (2008) The challenge of epilepsy control in deprived settings: low compliance and high fatality rates during a community-based phenobarbital program in rural Laos. Epilepsia 49: 539-540.
7. Tuan NA, Tomson T, Allebeck P, Chuc NT, Cuong le Q, (2009) The treatment gap of epilepsy in a rural district of Vietnam: a study from the EPIBAVI project. Epilepsia 50: 2320-2323.
8. Bhalla D, Chea K, Hun C, Vannareth M, Huc P, et al. (2012) Population-based study of epilepsy in Cambodia associated factors, measures of impact, stigma, quality of life, knowledge-attitude-practice, and treatment gap. PLoS One 7: e46296.
9. Bhalla D, Samleng C, Gerard D, Oum S, Druet-Cabanac M, et al. (2013) Epilepsy in Asia: A Cambodian Experience. Neuroepidemiology 40: 260-263.
10. CDHS (2005) Cambodian Demographic and Health Survey Phnom Penh, Cambodia: National Institute of Public Health and National Institute of Statistics.
11. From the Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22: 489-501.
12. Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34: 592-596.
13. Stevens D, (1997) Neurology in the United Kingdom-numbers of clinical neurologists and trainees. J Neurol Neurosurg Psychiatry 63: 67-72.
14. PAHO (2011) Strategy and plan of action on Epilepsy. Washiongton DC, USA: Pan-American Health Organization. 1-25 p.
15. WHO (2004) Epilepsy in the WHO African region: bridging the gap. Geneva, Switzerland: World Health Organization.
16. NIRD (2010) Development indicators for CIRDAP and SAARC countries. Andhra Pradesh, India: National Institute of Rural Development. 1-11 p.
17. Dayrit MM, Dolea C, Dreesch N, (2011) Addressing the HRH crisis in countries: how far have we gone? What can we expect to achieve by 2015? Rev Peru Med Exp Salud Publica 28: 327-336.
18. STATA (2012) STATA: data analysis and statistical software. Texas, USA: STATA.
19. Sander JW, (2004) The use of antiepileptic drugs-principles and practice. Epilepsia 45Suppl 6: 28-34.
20. Feksi AT, Kaamugisha J, Sander JW, Gatiti S, Shorvon SD, (1991) Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group). Lancet 337: 406-409.
21. Feksi AT, Kaamugisha J, Gatiti S, Sander JW, Shorvon SD, (1991) A comprehensive community epilepsy programme: the Nakuru project. Epilepsy Res 8: 252-259.
22. Watts AE, (1989) A model for managing epilepsy in a rural community in Africa. BMJ 298: 805-807.
23. Mani KS, Rangan G, Srinivas HV, Srindharan VS, Subbakrishna DK, (2001) Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet 357: 1316-1320.
24. Nimaga K, Desplats D, Doumbo O, Farnarier G, (2002) Treatment with phenobarbital and monitoring of epileptic patients in rural Mali. Bull World Health Organ 80: 532-537.
25. Bleck TP, (2007) Valproate was more effective than lamotrigine and better tolerated than topiramate in generalized or unclassified epilepsy. ACP J Club 147: 74-75.
26. Iivanainen M, Waltimo O, Tokola O, Parantainen J, Tamminen M, et al. (1990) A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy. Acta Neurol Scand 82: 121-125.
27. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D, (1997) Quality of life of people with epilepsy: a European study. Epilepsia 38: 353-362.
28. Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181: 30-35.
29. Buck D, Jacoby A, Baker GA, Chadwick DW, (1997) Factors influencing compliance with antiepileptic drug regimes. Seizure 6: 87-93.
30. Satishchandra P, Gururaj G, Mohammed Q, Senanayake D, Silpakit O (2001) Epilepsy: Out of the Shadows. WHO SEARO.
31. WHO (2001) Epilepsy in the WHO South-East Asian Region: Bridging the Gap. Delhi, India: World Health organization.
32. Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M, (1999) Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci 26: 263-270.
33. Boekaerts M, Roder I, (1999) Stress, coping, and adjustment in children with a chronic disease: a review of the literature. Disabil Rehabil 21: 311-337.
34. Ratsepp M, Oun A, Haldre S, Kaasik AE, (2000) Felt stigma and impact of epilepsy on employment status among Estonian people: exploratory study. Seizure 9: 394-401.
35. Sharon T (2011) Social and Psychological Issues in Patients with Epilepsy. Novel Aspects of Epilepsy.
36. Gopinath M, Sarma PS, Thomas SV, (2011) Gender-specific psychosocial outcome for women with epilepsy. Epilepsy Behav 20: 44-47.
37. Munson JF, (1910) Death in Epilepsy. Med Record 77: 58-62.
38. Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, et al. (1994) Mortality from epilepsy: results from a prospective population-based study. Lancet 344: 918-921.
39. Ryan CA, Dowling G, (1993) Drowning deaths in people with epilepsy. CMAJ 148: 781-784.
40. Olesen JB, Hansen PR, Erdal J, Abildstrom SZ, Weeke P, et al. (2010) Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 19: 518-524.
41. Jegannathan B, Kullgren G, (2011) Gender differences in suicidal expressions and their determinants among young people in Cambodia, a post-conflict country. BMC Psychiatry 11: 47.
42. Medina CO, Jegannathan B, Dahlblom K, Kullgren G, (2012) Suicidal expressions among young people in Nicaragua and Cambodia: a cross-cultural study. BMC Psychiatry 12: 28.
43. CDHS (2005) Cambodian Demographic and Health Survey. National Institute of Public Health and National Institute of Statistics, Phnom Penh.
44. Uy S, Akashi H, Taki K, Ito K, (2007) Current problems in national hospitals of Phnom Penh: finance and health care. Nagoya J Med Sci 69: 71-79.
45. Bhargava A, Docquier F, Moullan Y (2010) Modeling the effects of physician emigration on human development. New York, USA: World Bank.
46. Augustine A, John H, Graham R (2011) A review of health leadership and management capacity in Cambodia.
47. Henderson LN, Tulloch J, (2008) Incentives for retaining and motivating health workers in Pacific and Asian countries. Human Resources for Health 6: 1-20.